Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Melanoma 13 Colorectal Neoplasms 7 Carcinoma, Non-Small-Cell Lung 6 Neoplasm Metastasis 5 Neoplasms 4 Lung Neoplasms 4 Brain Neoplasms 4 Triple Negative Breast Neoplasms 2 Skin Neoplasms 2 Skin Diseases 2 Pancreatic Neoplasms 2 Hematologic Neoplasms 2 Uveal Melanoma 1 Spinocerebellar Degenerations 1 Solid Tumors Harboring a BRAF V600 Mutation 1 Soft Tissue Neoplasms 1 Peripheral Nervous System Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Noonan Syndrome 5 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma, Plexiform 1 Neurofibroma 1 Multiple Myeloma 1 Lymphoma 1 Lymphatic Metastasis 1 Low-grade Serous Ovarian Cancer 1 Leukemia, Myeloid, Acute 1 Hereditary Sensory and Autonomic Neuropathies 1 Gliosarcoma 1

Interventions

Temozolomide 47 Bevacizumab 41 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 Irinotecan 11 Nivolumab 8 Everolimus 7 Radiation 6 poly ICLC 5 X-Rays 5 Phantoms, Imaging 5 Carboplatin 5 pembrolizumab 4 fluorodopa F 18 4 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Granulocyte-Macrophage Colony-Stimulating Factor 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 palbociclib 3 ivosidenib 3 antineoplaston A10 3 Vorinostat 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Modafinil 3 Lomustine 3 Biopsy 3 veliparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Glioma × binimetinib × Clear all

NCT03973918 2024-10-31

BRAF

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Terminated

5 enrolled 15 charts

Astrocytoma, Glioblastoma, Glioma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡